Cargando…
Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin’s Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study
BACKGROUND: Development of novel therapeutic drugs and regimens for cancer treatment has led to improvements in patient long-term survival. This success has, however, been accompanied by the increased occurrence of second primary cancers. Indeed, patients who received regional radiotherapy for Hodgk...
Autores principales: | Boldrin, Elisa, Rumiato, Enrica, Fassan, Matteo, Cappellesso, Rocco, Rugge, Massimo, Chiarion-Sileni, Vanna, Ruol, Alberto, Alfieri, Rita, Cagol, Matteo, Castoro, Carlo, Amadori, Alberto, Saggioro, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303414/ https://www.ncbi.nlm.nih.gov/pubmed/25611972 http://dx.doi.org/10.1371/journal.pone.0117070 |
Ejemplares similares
-
Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer
por: Boldrin, Elisa, et al.
Publicado: (2019) -
Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study
por: Cavallin, Francesco, et al.
Publicado: (2017) -
Allelic Imbalance Analysis in Liquid Biopsy to Monitor Locally Advanced Esophageal Cancer Patients During Treatment
por: Boldrin, Elisa, et al.
Publicado: (2020) -
PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
por: Fassan, Matteo, et al.
Publicado: (2019) -
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
por: Fassan, Matteo, et al.
Publicado: (2016)